Wird geladen...
Immune Response to COVID-19 mRNA Vaccine—A Pilot Study
Twenty individuals (17 females, 3 males, aged 31–65 years (range), median: 46) who received both doses of the BioNTech Pfizer mRNA vaccine were examined (11 to 31 days, median: 25) after the second dose for the presence of antibodies against peptides of SARS-COV-2 and some of MERS-CoV, SARS-CoV1, HC...
Gespeichert in:
| Veröffentlicht in: | Vaccines (Basel) |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
MDPI
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8150284/ https://ncbi.nlm.nih.gov/pubmed/34064613 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/vaccines9050488 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|